![]() |
|
|
Forward to a colleague |
||
Access Full Stories In the latest twist in Roche's fight to acquire diagnostics expert Ventana, the companies have signed a confidentiality agreement that will enable the pharma giant access to Ventana's books... Read Accelrys offers academics its scientific operating system for free Accelrys is offering its SciTregic scientific operating system to academics for free to enable them to create software applications and share them with both academic and commercial communities... Read Evotec's metamorphosis erodes profit Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter... Read AstraZeneca in 'serious trouble', say analysts An analyst report released yesterday identified AstraZeneca as being in 'serious trouble' and branded it as potentially the 'worst [large cap] performer in [the] entire sector' over the next eight years... Read Giving lung cancer a Smac A small molecule version of a protein called Smac can turn the survival signal for a variety of tumour cells into a death signal and could be effective as a new class of drug, especially for lung cancer patients... Read |
||||||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||||||
CappAero pipettes - ultimate accuracy and intelligent design The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here | ||||||||||||||||||
|
Related Industry News BioCryst clinical trials debacle highlights protocol perils BioCryst's recent clinical trials debacle highlights the importance of the robust and realistic design of, and careful adherence to, a drug trial protocol... Read Pharmaceutical manufacturing: people on the move AstraZeneca, Cumberland Pharmaceuticals, Pieris, Theraptosis and InteKrin Therapeutics have all had people on the move in the world of pharmaceutical manufacturing... Read NPIL to trim ex-Pfizer site NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability... Read PharmEng opens new Canada plant Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||